Poland· PL-100223984
Hemosol BO
A b05zb, b05 product containing produkt złożony, registered in Poland by Vantive Belgium SRL.
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Produkt złożony
- Manufacturer
- Vantive Belgium SRL
- Country
- Poland (PL)
- ATC code
- B05ZB, B05
- ATC class
- B05ZB, B05
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990768905
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b255d98d-4a1e-4651-ad07-9892a37b72db GET /v1/drugs/b255d98d-4a1e-4651-ad07-9892a37b72db?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do hemofiltracji i hemodializy",
"source": "urpl",
"strength": "-",
"packaging": "05909990768905 ¦ Lz ¦ 56841\n2 worki 5000 ml",
"substance": "Calcii chloridum dihydricum 5,145 g (roztwór elektrolitów - komora A) + Magnesii chloridum hexahydricum 2,033 g (roztwór elektrolitów - komora A) + Acidum lacticum 5,4 g (roztwór elektrolitów - komora A) + Natrii hydrogenocarbonas 3,09 g (roztwór buforujący - komora B) + Natrii chloridum 6,45 g (roztwór buforujący - komora B)",
"common_name": "Produkt złożony",
"pl_product_id": "100223984",
"pozwolenie_nr": "16580",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about produkt złożony.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.